FDA Drug Application (022301) for APRISO by VALEANT PHARMS INTL

Back to FDA Applications sponsored by VALEANT PHARMS INTL

Application Number022301
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage375MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPRISO
Active IngredientMESALAMINE

Active IngredientCount
List of drugs with Active Ingredient MESALAMINE10


Back to FDA Applications sponsored by VALEANT PHARMS INTL